De Benedetti, F. Et Al. 2017. CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40. Annual European Congress of Rheumatology , (Madrid, Spain), 77.

De Benedetti, F., Gattorno, M., Frenkel, J., Calvo, I., Moutschen, M., Quartier, P., ... Kasapcopur, O.(2017). CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40 . Annual European Congress of Rheumatology (pp.77). Madrid, Spain

De Benedetti, F. Et Al. "CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40," Annual European Congress of Rheumatology, Madrid, Spain, 2017

De Benedetti, F. D. Et Al. "CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40." Annual European Congress of Rheumatology , Madrid, Spain, pp.77, 2017

De Benedetti, F. Et Al. (2017) . "CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40." Annual European Congress of Rheumatology , Madrid, Spain, p.77.

@conferencepaper{conferencepaper, author={F. De Benedetti Et Al. }, title={CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40}, congress name={Annual European Congress of Rheumatology}, city={Madrid}, country={Spain}, year={2017}, pages={77} }